(Q26998975)

21 June 2017

title

The role of glutamate and its receptors in autism and the use of glutamate receptor antagonists in treatment (English)

1 reference

21 June 2017

0 references

1

Donald C Rojas

1 reference

21 June 2017

language of work or name

1 reference

22 April 2014

1 reference

Journal of Neural Transmission

21 June 2017

published in

1 reference

21 June 2017

volume

121

1 reference

21 June 2017

issue

8

1 reference

21 June 2017

page(s)

891-905

1 reference

Increased glutamate and homocysteine and decreased glutamine levels in autism: a review and strategies for future studies of amino acids in autism

21 June 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134390

GABAB-mediated rescue of altered excitatory-inhibitory balance, gamma synchrony and behavioral deficits following constitutive NMDAR-hypofunction.

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134390

The 22q13.3 Deletion Syndrome (Phelan-McDermid Syndrome)

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134390

Rare deletions at the neurexin 3 locus in autism spectrum disorder

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134390

FMRP stalls ribosomal translocation on mRNAs linked to synaptic function and autism

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134390

Common circuit defect of excitatory-inhibitory balance in mouse models of autism

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134390

Neuroligin-1 deletion results in impaired spatial memory and increased repetitive behavior

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134390

Anxiety in children and adolescents with autism spectrum disorders

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134390

A pilot open label, single dose trial of fenobam in adults with fragile X syndrome.

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134390

A common genetic variant in the neurexin superfamily member CNTNAP2 increases familial risk of autism

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134390

Correction of fragile X syndrome in mice.

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134390

Contribution of SHANK3 mutations to autism spectrum disorder

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134390

Strong association of de novo copy number mutations with autism

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134390

Novel splice isoforms for NLGN3 and NLGN4 with possible implications in autism

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134390

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134390

A case of autism with an interstitial deletion on 4q leading to hemizygosity for genes encoding for glutamine and glycine neurotransmitter receptor sub-units (AMPA 2, GLRA3, GLRB) and neuropeptide receptors NPY1R, NPY5R

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134390

X-linked mental retardation and autism are associated with a mutation in the NLGN4 gene, a member of the neuroligin family

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134390

A genomewide screen of 345 families for autism-susceptibility loci

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134390

Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134390

Altered synaptic plasticity in a mouse model of fragile X mental retardation

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134390

Mapping autism risk loci using genetic linkage and chromosomal rearrangements

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134390

No evidence for involvement of genetic variants in the X-linked neuroligin genes NLGN3 and NLGN4X in probands with autism spectrum disorder on high functioning level

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134390

Memantine as adjunctive therapy in children diagnosed with autistic spectrum disorders: an observation of initial clinical response and maintenance tolerability

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134390

A retrospective study of memantine in children and adolescents with pervasive developmental disorders

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134390

NLGN3/NLGN4 gene mutations are not responsible for autism in the Quebec population

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134390

Linkage and association of the mitochondrial aspartate/glutamate carrier SLC25A12 gene with autism

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134390

Autism as a strongly genetic disorder: evidence from a British twin study

21 March 2017

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134390

21 March 2017

https://api.crossref.org/works/10.1007%2FS00702-014-1216-0

Alteration of plasma glutamate and glutamine levels in children with high-functioning autism

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134390

Shank3 deficiency induces NMDA receptor hypofunction via an actin-dependent mechanism

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134390

Hippocampal synaptic plasticity is impaired in the Mecp2-null mouse model of Rett syndrome

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134390

Kainate receptors and rhythmic activity in neuronal networks: hippocampal gamma oscillations as a tool

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134390

Altered synaptic physiology and reduced susceptibility to kainate-induced seizures in GluR6-deficient mice

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134390

Etiological heterogeneity in autism spectrum disorders: more than 100 genetic and genomic disorders and still counting

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134390

Autism spectrum disorders: developmental disconnection syndromes

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134390

The mGluR theory of fragile X mental retardation

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134390

Metabolic mapping of deep brain structures and associations with symptomatology in autism spectrum disorders

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134390

Aberrant basal ganglia metabolism in fragile X syndrome: a magnetic resonance spectroscopy study

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134390

Reduced subcortical glutamate/glutamine in adults with autism spectrum disorders: a [¹H]MRS study.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134390

Prospective investigation of autism and genotype-phenotype correlations in 22q13 deletion syndrome and SHANK3 deficiency

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134390

GABA estimation in the brains of children on the autism spectrum: measurement precision and regional cortical variation

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134390

Is metabotropic glutamate receptor 5 upregulated in prefrontal cortex in fragile X syndrome?

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134390

Memantine: a review of possible uses in child and adolescent psychiatry

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134390

Insulin-like growth factor-1 rescues synaptic and motor deficits in a mouse model of autism and developmental delay

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134390

A randomized double-blind, placebo-controlled trial of minocycline in children and adolescents with fragile x syndrome

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134390

A pilot open-label trial of minocycline in patients with autism and regressive features

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134390

Enzymes in the glutamate-glutamine cycle in the anterior cingulate cortex in postmortem brain of subjects with autism

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134390

Lack of association between NLGN3, NLGN4, SHANK2 and SHANK3 gene variants and autism spectrum disorder in a Chinese population

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134390

Impact of acamprosate on behavior and brain-derived neurotrophic factor: an open-label study in youth with fragile X syndrome

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134390

Rapamycin reverses impaired social interaction in mouse models of tuberous sclerosis complex

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134390

Increased glutamate concentration in the auditory cortex of persons with autism and first-degree relatives: a (1)H-MRS study

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134390

TARGETED TREATMENTS IN AUTISM AND FRAGILE X SYNDROME

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134390

PET and SPECT tracers for glutamate receptors

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134390

Novel therapeutic targets in depression: minocycline as a candidate treatment.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134390

Multiple roles for mammalian target of rapamycin signaling in both glutamatergic and GABAergic synaptic transmission

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134390

Elevated glutamatergic compounds in pregenual anterior cingulate in pediatric autism spectrum disorder demonstrated by 1H MRS and 1H MRSI.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134390

Rare mutations in N-methyl-D-aspartate glutamate receptors in autism spectrum disorders and schizophrenia.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134390

New AMPA antagonists in epilepsy.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134390

Minocycline- and tetracycline-class antibiotics are protective against partial seizures in vivo.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134390

An open-label naturalistic pilot study of acamprosate in youth with autistic disorder

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134390

The NMDA receptor complex as a therapeutic target in epilepsy: a review

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134390

Molecular mechanisms of fragile X syndrome: a twenty-year perspective

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134390

Metabotropic glutamate receptor 5 upregulation in children with autism is associated with underexpression of both Fragile X mental retardation protein and GABAA receptor beta 3 in adults with autism

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134390

Recurrence risk for autism spectrum disorders: a Baby Siblings Research Consortium study

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134390

In vivo variation in metabotropic glutamate receptor subtype 5 binding using positron emission tomography and [11C]ABP688.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134390

In vivo detection of GABA and glutamate with MEGA-PRESS: reproducibility and gender effects

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134390

GABAB receptor modulation of synaptic function

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134390

Autism spectrum disorders--a genetics review

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134390

Glutamate receptor dysfunction and drug targets across models of autism spectrum disorders

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134390

Epigenetic modification of the FMR1 gene in fragile X syndrome is associated with differential response to the mGluR5 antagonist AFQ056.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134390

In vivo 1H-magnetic resonance spectroscopy study of the attentional networks in autism

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134390

Validating γ oscillations and delayed auditory responses as translational biomarkers of autism

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134390

Rapamycin for treating Tuberous sclerosis and Autism spectrum disorders

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134390

Autism and ADHD: how far have we come in the comorbidity debate?

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134390

Family-based association testing of glutamate transporter genes in autism

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134390

Seizures in fragile X syndrome: characteristics and comorbid diagnoses

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134390

Open-label add-on treatment trial of minocycline in fragile X syndrome

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134390

Sibling recurrence and the genetic epidemiology of autism

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134390

Autism spectrum disorders and epilepsy: moving towards a comprehensive approach to treatment

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134390

Autism and epilepsy: historical perspective

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134390

Deletions of NRXN1 (neurexin-1) predispose to a wide spectrum of developmental disorders

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134390

MEG detection of delayed auditory evoked responses in autism spectrum disorders: towards an imaging biomarker for autism

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134390

Metabotropic glutamate receptors: physiology, pharmacology, and disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134390

Incidence of fragile X syndrome by newborn screening for methylated FMR1 DNA.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134390

Emerging role of glutamate in the pathophysiology of major depressive disorder.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134390

Overrepresentation of mood and anxiety disorders in adults with autism and their first-degree relatives: what does it mean?

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134390

Reduced neural synchronization of gamma-band MEG oscillations in first-degree relatives of children with autism

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134390

Neurexin 1alpha structural variants associated with autism

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134390

Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134390

The fragile X prevalence paradox

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134390

Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134390

Elevated NMDA receptor levels and enhanced postsynaptic long-term potentiation induced by prenatal exposure to valproic acid

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134390

Genetic testing in autism: how much is enough?

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134390

Decreased GAD67 mRNA levels in cerebellar Purkinje cells in autism: pathophysiological implications

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134390

Increased serum levels of glutamate in adult patients with autism.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134390

Characteristics of fetal anticonvulsant syndrome associated autistic disorder.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134390

Screening of nine candidate genes for autism on chromosome 2q reveals rare nonsynonymous variants in the cAMP-GEFII gene

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134390

Linkage and association of the glutamate receptor 6 gene with autism

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134390

Postmortem brain abnormalities of the glutamate neurotransmitter system in autism

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134390

A genomewide screen for autism: strong evidence for linkage to chromosomes 2q, 7q, and 16p.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134390

Genetics and child psychiatry: II Empirical research findings

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134390

Hypothesis: is infantile autism a hypoglutamatergic disorder? Relevance of glutamate - serotonin interactions for pharmacotherapy

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134390

Mutations affecting synaptic levels of neurexin-1β in autism and mental retardation

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134390

Chronic pharmacological mGlu5 inhibition corrects fragile X in adult mice

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134390

Autism profiles of males with fragile X syndrome

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134390

Clinical heterogeneity of the autistic syndrome: a study of 60 families

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134390

Plasma amino acid levels in children with autism and their families

31 May 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-014-1216-0

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-014-1216-0

Density and distribution of hippocampal neurotransmitter receptors in autism: an autoradiographic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-014-1216-0

Rare variants analysis of neurexin-1β in autism reveals a novel start codon mutation affecting protein levels at synapses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-014-1216-0

Atypical developmental patterns of brain chemistry in children with autism spectrum disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-014-1216-0

Dysregulation of group-I metabotropic glutamate (mGlu) receptor mediated signalling in disorders associated with Intellectual Disability and Autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-014-1216-0

Evidence for cortical dysfunction in autism: a proton magnetic resonance spectroscopic imaging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-014-1216-0

Multi-voxel magnetic resonance spectroscopy at 3T in patients with idiopathic generalised epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-014-1216-0

NMDA receptor hypofunction in the dentate gyrus and impaired context discrimination in adult Fmr1 knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-014-1216-0

Open-label memantine in fragile X syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-014-1216-0

Brief report: acamprosate in fragile X syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-014-1216-0

STX209 (arbaclofen) for autism spectrum disorders: an 8-week open-label study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-014-1216-0

The hyperglutamatergic hypothesis of autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-014-1216-0

Glutamic acid decarboxylase 65 and 67 kDa proteins are reduced in autistic parietal and cerebellar cortices

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-014-1216-0

Memantine as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-014-1216-0

Neuroprotectant minocycline depresses glutamatergic neurotransmission and Ca(2+) signalling in hippocampal neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-014-1216-0

Non-invasive evaluation of the GABAergic/glutamatergic system in autistic patients observed by MEGA-editing proton MR spectroscopy using a clinical 3 tesla instrument

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-014-1216-0

Acamprosate inhibits the binding and neurotoxic effects of trans-ACPD, suggesting a novel site of action at metabotropic glutamate receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-014-1216-0

Reduced prefrontal glutamate/glutamine and gamma-aminobutyric acid levels in major depression determined using proton magnetic resonance spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-014-1216-0

A prevalence study of autism in tuberous sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-014-1216-0

Further characterization of the autism susceptibility locus AUTS1 on chromosome 7q.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-014-1216-0

Prevalence of parent-reported diagnosis of autism spectrum disorder among children in the US, 2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-014-1216-0

Glutamate antagonists seem to be slightly effective in psychopharmacologic treatment of autism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-014-1216-0

A prospective, open-label trial of memantine in the treatment of cognitive, behavioral, and memory dysfunction in pervasive developmental disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-014-1216-0

Increased GABA(B) receptor-mediated signaling reduces the susceptibility of fragile X knockout mice to audiogenic seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-014-1216-0

Rett syndrome: 1H spectroscopic imaging at 4.1 Tesla

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-014-1216-0

Anterior cingulate neurochemistry in social anxiety disorder: 1H-MRS at 4 Tesla

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-014-1216-0

The behavioral phenotype in fragile X: symptoms of autism in very young children with fragile X syndrome, idiopathic autism, and other developmental disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-014-1216-0

Decreased left perisylvian GABA concentration in children with autism and unaffected siblings

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-014-1216-0

Serotonin and amino acid content in platelets of autistic children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-014-1216-0

Behavioral alterations in rats prenatally exposed to valproic acid: animal model of autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-014-1216-0

The metabotropic glutamate receptor 8 gene at 7q31: partial duplication and possible association with autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-014-1216-0

Differential effects of aging and insulin-like growth factor-1 on synapses in CA1 of rat hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-014-1216-0

Family-based association study between autism and glutamate receptor 6 gene in Chinese Han trios

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-014-1216-0

Proton magnetic resonance spectroscopy study of brain metabolite changes after antipsychotic treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-014-1216-0

Distinct plasma profile of polar neutral amino acids, leucine, and glutamate in children with Autism Spectrum Disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-014-1216-0

Underutilization of genetics services for autism: the importance of parental awareness and provider recommendation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-014-1216-0

A magnetic resonance spectroscopy investigation of obsessive-compulsive disorder and anxiety.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-014-1216-0

Suppression of two major Fragile X Syndrome mouse model phenotypes by the mGluR5 antagonist MPEP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-014-1216-0

Family based association of GRIN2A and GRIN2B with Korean autism spectrum disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-014-1216-0

Rescue of NMDAR-dependent synaptic plasticity in Fmr1 knock-out mice

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134390

Analysis of the genes encoding neuroligins NLGN3 and NLGN4 in Bulgarian patients with autism

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134390

Magnetic resonance spectroscopy study of the glutamatergic system in adolescent males with high-functioning autistic disorder: a pilot study at 4T.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134390

In vivo 1H-magnetic resonance spectroscopy study of amygdala-hippocampal and parietal regions in autism

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134390

Double-blind, placebo-controlled study of amantadine hydrochloride in the treatment of children with autistic disorder.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134390

The postsynaptic NMDA-receptor--PSD-95 signaling complex in excitatory synapses of the brain.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134390

Plasma excitatory amino acids in autism.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4134390

Down-regulation of glial glutamate transporters after glutamatergic denervation in the rat brain

28 November 2018

1 reference

12 December 2020

Effects of STX209 (arbaclofen) on neurobehavioral function in children and adults with fragile X syndrome: a randomized, controlled, phase 2 trial

1 reference

12 December 2020

Overexpression of GluR6 in rat hippocampus produces seizures and spontaneous nonsynaptic bursting in vitro

1 reference

12 December 2020

The two different effects of the potential neuroprotective compound minocycline on AMPA-type glutamate receptors

1 reference

12 December 2020

10.1007/S00702-014-1216-0

Identifiers

DOI

1 reference

Dimensions Publication ID

21 June 2017

1008322380

0 references

OpenCitations bibliographic resource ID

4294851

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

4294851

1 reference